Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy Meeting Abstract

  

Authors:	Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; Modi, S.; Troso-Sandoval, T.; Argolo, D.; Jack, K.; Ulaner, G.; Jochelson, M.; Baselga, J.; Norton, L.; Hudis, C. A.; Dang, C. T.
Abstract Title:	Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
Meeting Title:	2016 San Antonio Breast Cancer Symposium (SABCS)
Journal Title:	Cancer Research
Volume:	77
Issue:	4 Suppl.
Meeting Dates:	2016 Dec 6-10
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2017-02-01
Language:	English
ACCESSION:	WOS:000397999002002
DOI:	10.1158/1538-7445.sabcs16-p4-21-34
PROVIDER:	wos
Notes:	Meeting Abstract: P4-21-34 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/109951